申请人:QUANTICEL PHARMACEUTICALS, INC.
公开号:US20160194315A1
公开(公告)日:2016-07-07
The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted pyrrolopyridine derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition of histone demethylase. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.
本发明涉及治疗癌症和肿瘤疾病的组合物和方法。本发明提供了取代吡咯吡啶衍生物化合物和含有该化合物的制药组合物。所述化合物和组合物可用于抑制组蛋白去甲基化酶。此外,所述化合物和组合物可用于治疗癌症,如前列腺癌、乳腺癌、膀胱癌、肺癌和/或黑色素瘤等。